Menu

Acceleron Pharma Inc. XLRN

Full chart Compare
Set alert

Price alert · XLRN

All alert types
178.75 +178.75

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $1.30MExpenses → Selling, General & Admin: $85.91MExpenses → Research & Development: $173.92MExpenses → Income Tax: $21.00KGross Profit → Expenses: $92.52MRevenue → Gross Profit: $92.52MNet Loss → Expenses: $166.03MOther Income$1.30MGross Profit$92.52MNet Loss$166.03MExpenses$259.85MSelling, General & Admin$85.91MResearch & Development$173.92MIncome Tax$21.00KRevenue$92.52M

Latest period ending Dec 31, 2020 · select a line to chart its full history

Annual income statement

XLRN annual income statement
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
92.52M73.99M13.99M13.48M27.77M
92.52M73.99M13.99M13.48M27.77M
92.52M73.99M13.99M13.48M27.77M
259.83M210.44M138.41M123.46M93.88M
173.92M153.95M103.90M89.73M68.58M
85.91M56.48M34.50M33.74M25.30M
-167.31M-136.44M-124.41M-109.98M-66.11M
21.00K-62.00K-27.00K32.00K24.00K
-166.03M-124.86M-118.87M-108.45M-57.01M
-166.03M-124.86M-118.87M-108.45M-57.01M
-166.03M-124.86M-118.87M-108.45M-57.01M
-166.03M-124.86M-118.87M-108.45M-57.01M
-2.92-2.38-2.59-2.68-1.52
-2.92-2.38-2.59-2.68-1.52
-2.92-2.38-2.59-2.68-1.52
-166.01M-124.92M-118.90M-108.42M-56.99M
-166.01M-124.92M-118.90M-108.42M-56.99M
56.80M52.45M45.90M40.42M37.43M
56.80M52.45M45.90M40.42M37.43M